Skip to main content
logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.96
+1.80 (19.65%)
Feb 27, 2026, 10:40 AM EST - Market open

Relay Therapeutics Revenue

In the year 2025, Relay Therapeutics had annual revenue of $15.36M with 53.44% growth. Relay Therapeutics had revenue of $7.00M in the quarter ending December 31, 2025.

Revenue (ttm)
$15.36M
Revenue Growth
+53.44%
P/S Ratio
106.62
Revenue / Employee
$81,676
Employees
188
Market Cap
1.96B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.36M5.35M53.44%
Dec 31, 202410.01M-15.54M-60.83%
Dec 31, 202325.55M24.17M1,749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 202082.65M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx407.32M
Immunocore Holdings400.02M
Iovance Biotherapeutics263.50M
AnaptysBio169.47M
Nurix Therapeutics83.98M
Tango Therapeutics66.50M
Intellia Therapeutics57.53M
Revenue Rankings

RLAY News

More News